Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Compelling Reasons to Buy?
View:
Post by Bookworm28 on Sep 15, 2022 7:24pm

Compelling Reasons to Buy?

Can someone give me a couple of reasons why anyone would want to own PMN shares? Seems like their computational approach isn't getting much traction. TIA.
Comment by BottomBroker on Sep 16, 2022 10:05am
1. They are a couple of months away from filing a IND with the FDA. 2. Shortly after that, they will begin Phase I trials for their AD drug PMN 310. If the results of said trials show that the drug is effective (and that's a very, very big "if"), the share price will explode and/or they will partner/be bought out by big pharma and we'll all be filthy, stinking rich. So, roll the ...more  
Comment by M101 on Sep 16, 2022 10:48am
Other than buying the regulator, what approach is getting traction?
Comment by azzymaa on Sep 19, 2022 11:55am
Don't buy this junk, and don't listen to anyone on this Board. They are deep in the hole and will make up bogus stories. Check their post history.
Comment by bball67 on Sep 20, 2022 12:53pm
You are not going to be convinced or compelled by what someone says. You need to do the work. I own more than half of 1% of this company. This is going to be more than a grand slam home run.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities